You just read:

Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical Trial of PRV-300 in Patients with Moderate-to-Severe Ulcerative Colitis

News provided by

Provention Bio, Inc.

May 08, 2019, 16:25 ET